Skip to content
Search AI Powered

Latest Stories

Military Invests in MDMA for PTSD Treatment

In a historic shift, the Department of Defense is funding two major clinical trials—totaling $9.8 million—to study the use of MDMA-assisted therapy for treating PTSD in active-duty service members. The research marks the first sanctioned exploration of psychedelics within the military. While the move signals progress, broader access to alternative therapies like cannabis and psilocybin remains blocked—leaving many veterans still fighting for healing options the government won’t yet fund.

the pentagon, washington dc, aerial view

The Pentagon Is Betting Nearly $10 Million on MDMA to Treat PTSD in Active-Duty Soldiers

The U.S. Department of Defense (DoD) has earmarked $9.8 million for pioneering research into the therapeutic potential of psychedelics, specifically MDMA, for active-duty service members grappling with post-traumatic stress disorder (PTSD). This initiative underscores a significant shift in military mental health strategies, acknowledging the pressing need for innovative treatments amid rising concerns over service members' well-being.Latest news & breaking headlines+1Military Times+1

Breaking Down the Investment


The funding is divided into two equal grants of $4.9 million:Military Times

  • Walter Reed National Military Medical Center: Set to conduct a double-blind, placebo-controlled trial, this study will administer MDMA to active-duty Army personnel diagnosed with mild to moderate PTSD. The primary objective is to assess how MDMA influences psychological flexibility, a key factor in effective PTSD treatment. Leading this research is Major Aaron Wolfgang, head of Inpatient Psychiatry at Walter Reed, who has previously contributed to comprehensive reviews on MDMA-assisted therapy. Military Times+1Latest news & breaking headlines+1
  • Emory University and STRONG STAR Consortium: Collaborating with the University of Texas Health Science Center at San Antonio, this partnership will explore MDMA-assisted therapy's efficacy in treating PTSD among active-duty troops. STRONG STAR is renowned for its focus on combat-related PTSD research, making it a pivotal player in this groundbreaking study.

A Historical Perspective

This endeavor marks the first sanctioned investigation into MDMA's therapeutic applications for PTSD within active-duty military personnel. Historically, the U.S. government's engagement with psychedelics in military contexts has been controversial, often associated with unauthorized experiments during the mid-20th century. This contemporary research signifies a departure from past practices, emphasizing scientific rigor and ethical standards.

The Broader Context: Veterans and Alternative Therapies

While the DoD's commitment to exploring psychedelics is a progressive step, it occurs against a backdrop of governmental resistance to alternative treatments for veterans. Efforts to expand access to cannabis and psychedelics for medical purposes have faced legislative hurdles. For instance, amendments proposing research into psilocybin and MDMA for PTSD and traumatic brain injury were recently rejected, leaving many veterans without access to potentially life-changing therapies.

FDA Approves Landmark Cannabis for PTSD in Veterans - The BluntnessFDA Approves Landmark Cannabis for PTSD in Veterans - The Bluntness Photo by Wesley Tingey on Unsplash

The Imperative for Innovative Solutions

The urgency for effective mental health interventions in the military community cannot be overstated. Studies have shown that women veterans are 1.8 times more likely than their civilian counterparts to commit suicide, highlighting the critical need for comprehensive and effective treatment options.

The DoD's $9.8 million investment in psychedelic research represents a hopeful development in addressing the complex mental health challenges faced by service members. As these studies progress, they hold the potential to reshape treatment paradigms and offer new avenues for healing to those who have served.

More For You

Comprehensive Glossary of Cannabis Terminology - The Bluntness
Cannabis Terminology - The Bluntness
Photo by Margo Amala on Unsplash

Are You Ready to Master Cannabis Lingo? Explore Essential Terms Now

This glossary covers key cannabis-related terms that can help consumers better understand the cannabis industry, products, and their effects. Whether you're new to cannabis or looking to deepen your knowledge, these definitions offer clarity on common terms you might encounter.

Cannabis Basics: What is Cannabis?

Cannabis is a fascinating plant species that includes three main types: Cannabis sativa, Cannabis indica, and Cannabis ruderalis. Each of these species has unique characteristics and effects. The cannabis plant is a complex organism, rich in various compounds such as cannabinoids, terpenes, and flavonoids. These compounds contribute to the plant’s diverse range of effects and therapeutic benefits. Cannabis plants are cultivated for both medicinal and recreational purposes, and they can be consumed in multiple forms, including dried flower, extracts, and edibles. Whether you’re interested in the energizing effects of Cannabis sativa, the relaxing properties of Cannabis indica, or the unique traits of Cannabis ruderalis, there’s a cannabis plant to suit every need.

Cannabis Products: Cannabis Extracts

Cannabis extracts are highly potent products derived from the cannabis plant using various extraction methods, such as solvents or CO2. These extracts are concentrated forms of cannabis that can be used in several ways, including dabbing, vaporizing, or as ingredients in edibles and topicals. There are several types of cannabis extracts, each with its own texture and potency, including wax, shatter, oil, and crumble. These products are often favored for their high cannabinoid content and are commonly used for medicinal purposes, such as pain relief and anxiety management. Whether you’re looking for a powerful dabbing experience or a potent ingredient for your homemade edibles, cannabis extracts offer a versatile and effective option.

Keep ReadingShow less
farmers market, fruits, vegetables for sale
New York's Farmers Markets Expand as Corporate Giants Wait on Sidelines
Photo by Jacopo Maiarelli on Unsplash

Cannabis Farmers Markets Here to Stay

Governor Kathy Hochul signed legislation last week that permanently establishes cannabis farmers markets across New York State, a move that could significantly reshape the state's cannabis retail landscape during a period of ongoing regulatory challenges.

A Permanent Solution Emerges

The newly signed bill (S.7956/A.8762) transforms what began as a temporary program in 2023 into a permanent fixture of New York's cannabis ecosystem. The legislation allows licensed cultivators and processors to sell their products directly to consumers at approved market locations throughout the state, creating a farm-to-consumer pipeline previously unavailable in the traditional retail structure.

Keep ReadingShow less
Socrates contemplates the Greek government's confusion over medical cannabis.
Socrates contemplates the Greek government's confusion over medical cannabis.

Medical Cannabis in Greece? The Greek Government Has No Idea What It’s Doing

The Greek government has finally given the approval for THC-rich medical cannabis cultivation and sale.

The Minister of Development Adonis Georgiadis, who is apparently now spearheading cannabis reform in the country, even issued a “mea culpa,” admitting that he and his colleagues had been wrong about cannabis in the past.

Keep ReadingShow less
Russia Has Detained WNBA Star Brittney Griner — Here's What We Know
Russia Has Detained WNBA Star Brittney Griner — Here's What We Know
NowThis News

WNBA Superstar Brittney Griner Detained in Russia over Alleged Cannabis Possession

March 8, 2022 -- Brittney Griner, two-time Olympic Gold medalist and seven-time WNBA all-star, is in serious trouble.

The Russian Federal Customs Service released a statement on Saturday, confirming they had detained the 31-year-old superstar athlete in a Moscow airport last month after agents supposedly found cannabis vape cartridges in her luggage.

Keep ReadingShow less
Cannabis and Aging: A Groundbreaking Study Challenges Long-Held Beliefs - The Bluntness
Cannabis and Aging: A Groundbreaking Study Challenges Long-Held Beliefs - The Bluntness
Giphy

Aging & Cannabis: New Findings

For decades, cannabis has been widely regarded as a substance with potential cognitive risks, particularly when used over long periods. Governments across the globe have classified it as a controlled substance, citing concerns about the effects of marijuana use, including memory loss, diminished executive function, and long-term neurological impact. But new research is challenging this long-standing assumption, suggesting that cannabis use may not be linked to age-related cognitive decline—and might even be associated with better cognitive preservation over time.

A recent study published in PubMed (NIH, 2024) followed over 5,000 men for more than four decades to analyze the long-term cognitive effects of cannabis use. The results? Men with a history of cannabis use experienced less cognitive decline from early adulthood to late midlife compared to those who never used cannabis.

Keep ReadingShow less